Patents by Inventor Andrew Kinloch

Andrew Kinloch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS RELATED TO BCL2 AND BIM HETERODIMER ANTIBODIES
    Publication number: 20240043529
    Abstract: The present disclosure relates to compositions and methods of determining cancer cell sensitivity to treatment using antibodies that detect heterodimers comprising Bc1-2 proteins selected from Bc12 and BIM. The disclosure also provides methods for predicting a cancer patient's sensitivity to the cancer treatment.
    Type: Application
    Filed: December 22, 2021
    Publication date: February 8, 2024
    Inventors: Michael H. CARDONE, Andrew KINLOCH, Stephen GILLIES
  • Methods for diagnosing rheumatoid arthritis
    Patent number: 9334487
    Abstract: The present invention relates to methods of diagnosing, prognosing, preventing or delaying onset of or treating rheumatoid arthritis, methods of distinguishing between different types or stages of rheumatoid arthritis, of identifying an individual at risk of developing rheumatoid arthritis, and of monitoring efficacy of a treatment regime in an individual being treated for rheumatoid arthritis, using a citrullinated enolase peptide to detect or capture antibodies associated with rheumatoid arthritis.
    Type: Grant
    Filed: October 22, 2012
    Date of Patent: May 10, 2016
    Assignee: IMPERIAL INNOVATIONS LIMITED
    Inventors: Karin Lundberg, Patrick Venables, Andrew Kinloch
  • METHODS
    Publication number: 20100047256
    Abstract: The present invention relates to methods of diagnosing, prognosing, preventing or delaying onset of or treating rheumatoid arthritis, methods of distinguishing between different types or stages of rheumatoid arthritis, of identifying an individual at risk of developing rheumatoid arthritis, and of monitoring efficacy of a treatment regime in an individual being treated for rheumatoid arthritis, using a citrullinated enolase peptide to detect or capture antibodies associated with rheumatoid arthritis.
    Type: Application
    Filed: January 25, 2007
    Publication date: February 25, 2010
    Applicant: IMPERIAL INNOVATIONS LIMITED
    Inventors: Karin Lundberg, Patrick Venables, Andrew Kinloch